GENEREX BIOTECHNOLOGY CORP 4

4 · GENEREX BIOTECHNOLOGY CORP · Filed Feb 12, 2016

Form 4

Period: 2016-02-09

Chief Operating Officer

Transactions

Exercise/Conversion
Common Stock
2016-02-09$0.00/sh+5,583,775$5,584→ 3,916,104 total
Exercise/Conversion
Common Stock Purchase Option
2016-02-09−546,448→ 0 total
Exercise: $0.00From: 2012-06-20Exp: 2017-06-19→ Common Stock (546,448 underlying)
Exercise/Conversion
Common Stock Purchase Option
2016-02-09−1,928,925→ 0 total
Exercise: $0.00From: 2013-04-01Exp: 2018-04-01→ Common Stock (1,928,925 underlying)
Exercise/Conversion
Common Stock Purchase Option
2016-02-09−595,239→ 0 total
Exercise: $0.00From: 2013-06-06Exp: 2018-06-06→ Common Stock (595,239 underlying)
Exercise/Conversion
Common Stock Purchase Option
2016-02-09−845,492→ 0 total
Exercise: $0.00From: 2014-01-01Exp: 2018-10-31→ Common Stock (845,942 underlying)
Exercise/Conversion
Common Stock Purchase Option
2016-02-09+1,667,671→ 1,667,671 total
Exercise: $0.00From: 2016-02-09Exp: 2020-10-26→ Common Stock (1,667,671 underlying)

Documents

1 file